X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (579) 579
Book Review (101) 101
Publication (30) 30
Patent (17) 17
Book Chapter (14) 14
Conference Proceeding (12) 12
Book / eBook (5) 5
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (363) 363
humans (358) 358
female (194) 194
male (188) 188
aged (161) 161
middle aged (142) 142
hematology (123) 123
peripheral vascular disease (120) 120
risk factors (116) 116
venous thromboembolism (112) 112
anticoagulants - therapeutic use (107) 107
pulmonary embolism (98) 98
aged, 80 and over (94) 94
anticoagulants (88) 88
deep-vein thrombosis (85) 85
thromboembolism (84) 84
abridged index medicus (81) 81
adult (81) 81
treatment outcome (81) 81
medicine, general & internal (68) 68
stroke (68) 68
risk (66) 66
cardiac & cardiovascular systems (61) 61
prevention (60) 60
prospective studies (57) 57
molecular-weight heparin (56) 56
warfarin (54) 54
care and treatment (52) 52
anticoagulants - adverse effects (51) 51
anticoagulants - administration & dosage (48) 48
hemorrhage - chemically induced (48) 48
thrombosis (48) 48
atrial fibrillation (47) 47
prognosis (46) 46
pulmonary-embolism (46) 46
venous thrombosis (45) 45
internal medicine (44) 44
heparin (43) 43
medicine & public health (43) 43
acute disease (42) 42
time factors (42) 42
cancer (41) 41
mortality (41) 41
diagnosis (40) 40
fibrinolytic agents - therapeutic use (40) 40
administration, oral (39) 39
clinical neurology (38) 38
drug therapy (38) 38
pulmonary embolism - drug therapy (37) 37
prophylaxis (36) 36
recurrence (36) 36
risk assessment (36) 36
therapy (36) 36
venous thromboembolism - prevention & control (36) 36
thrombolytic therapy (34) 34
double-blind method (33) 33
enoxaparin (33) 33
management (33) 33
deep vein thrombosis (32) 32
follow-up studies (32) 32
heparin - therapeutic use (32) 32
incidence (32) 32
surgery (32) 32
heparin, low-molecular-weight - therapeutic use (31) 31
venous thromboembolism - drug therapy (31) 31
analysis (29) 29
dabigatran (29) 29
venous thrombosis - prevention & control (29) 29
rivaroxaban (28) 28
thromboembolism - prevention & control (28) 28
italy - epidemiology (27) 27
patients (27) 27
registries (26) 26
thrombolysis (26) 26
double-blind (25) 25
research (25) 25
secondary prevention (25) 25
respiratory system (24) 24
stroke - etiology (24) 24
trial (24) 24
drug administration schedule (23) 23
metaanalysis (23) 23
pulmonary embolism - mortality (23) 23
logistic models (22) 22
postoperative complications - prevention & control (22) 22
predictive value of tests (22) 22
randomized controlled trials as topic (22) 22
venous thrombosis - etiology (22) 22
bleeding (21) 21
italy (21) 21
venous thrombosis - drug therapy (21) 21
adolescent (20) 20
apixaban (20) 20
guidelines (20) 20
health risk assessment (20) 20
hematology, oncology and palliative medicine (20) 20
stroke - prevention & control (20) 20
unfractionated heparin (20) 20
venous thromboembolism - etiology (20) 20
vitamin k - antagonists & inhibitors (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (585) 585
Italian (24) 24
German (6) 6
French (5) 5
Polish (2) 2
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CIRCULATION, ISSN 0009-7322, 10/2007, Volume 116, Issue 17, pp. F99 - F101
Giancarlo Agnelli, MD, professor of internal medicine at the University of Perugia, Italy, and director of the division of internal and cardiovascular... 
CARDIAC & CARDIOVASCULAR SYSTEMS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 781 - 783
Journal Article
Current vascular pharmacology, ISSN 1570-1611, 01/2014, Volume 12, Issue 3, pp. 351 - 352
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 10, pp. 943 - 949
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 21, pp. 1959 - 1967
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 15, pp. 1402 - 1411
In a randomized trial, 1006 patients with intermediate-risk pulmonary embolism were assigned to tenecteplase or placebo in addition to standard heparin... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | VENOUS THROMBOEMBOLISM | ELEVATION | COMPLICATIONS | ECHOCARDIOGRAPHY | THROMBOLYTIC THERAPY | RIGHT-VENTRICULAR ENLARGEMENT | PROGNOSTIC ROLE | Pulmonary Embolism - complications | Age Factors | Double-Blind Method | Humans | Middle Aged | Risk Factors | Heparin - therapeutic use | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Pulmonary Embolism - mortality | Fibrinolytic Agents - adverse effects | Stroke - chemically induced | Fibrinolytic Agents - therapeutic use | Ventricular Dysfunction, Right - etiology | Aged, 80 and over | Troponin - blood | Female | Pulmonary Embolism - drug therapy | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Pulmonary embolism | Evaluation | Usage | Care and treatment | Fibrinolysis | Heart | Stroke | Heart attacks | Echocardiography | Embolisms | Pulmonary arteries | Lung | Hemorrhage | Bleeding | Embolism | Blood clots | Troponin T | Fibrin | Troponin | Troponin I | Motivation | Computed tomography | Ischemia | Calcium-binding protein | Heparin | Ventricle | Drug therapy | Index Medicus | Abridged Index Medicus | Ventricular Dysfunction, Right | Fibrinolytic Agents | Life Sciences | Tissue Plasminogen Activator | Pulmonary Embolism
Journal Article
European Respiratory Journal, ISSN 0903-1936, 01/2017, Volume 49, Issue 1, pp. 1601732 - 1601732
The correspondence by S. Ozsu concerns several issues. The first issue is the identification of low-risk patients with acute pulmonary embolism. According to... 
RESPIRATORY SYSTEM | Risk | Acute Disease | Pulmonary Embolism | Risk Assessment | Cardiology | Humans | Cardiac arrhythmia | Medical imaging | Angiography | Risk groups | Embolisms | Pulmonary arteries | Lung | Mortality | Embolism | Troponin | Computed tomography | Calcium-binding protein | Electrocardiography | Biomarkers | Ventricle | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 7, pp. 601 - 609
Patients with advanced cancer are at increased risk for venous thrombosis and thromboembolism related to both the effects of cancer and its treatment. In this... 
CONTROLLED CLINICAL-TRIAL | SURGERY | MEDICINE, GENERAL & INTERNAL | EVENTS | VENOUS THROMBOEMBOLISM | PROGNOSTIC-FACTORS | COMPETING RISK | THROMBOSIS | BEVACIZUMAB | MOLECULAR-WEIGHT HEPARIN | PREVENTION | Double-Blind Method | Hemorrhage - epidemiology | Humans | Risk Factors | Kaplan-Meier Estimate | Heparin, Low-Molecular-Weight - adverse effects | Antineoplastic Agents - therapeutic use | Heparin, Low-Molecular-Weight - therapeutic use | Incidence | Neoplasms - drug therapy | Venous Thromboembolism - etiology | Fibrinolytic Agents - adverse effects | Fibrinopeptide A - adverse effects | Neoplasms - complications | Venous Thromboembolism - prevention & control | Fibrinopeptide A - therapeutic use | Antineoplastic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Adult | Venous Thromboembolism - epidemiology | Drugs | Cancer patients | Care and treatment | Drug utilization | Anticoagulants (Medicine) | Dosage and administration | Product/Service Evaluations | Thromboembolism | Drug therapy | Health aspects | Methods | Thrombolytic therapy | Anticoagulants | Embolisms | Prophylaxis | Clinical trials | Metastasis | Thrombosis | Cancer therapies | Patients | Bleeding | Embolism | Metastases | Studies | Chemotherapy | Heparin | Solid tumors | Health risk assessment | Drug dosages | Cancer | Index Medicus | Abridged Index Medicus
Journal Article